<!DOCTYPE html>
<html>
<head>
    <meta charset="UTF-8">
    <title>Extracted Document</title>
    <style>
        body { font-family: Arial, sans-serif; max-width: 900px; margin: 0 auto; padding: 20px; }
        h1, h2, h3 { color: #333; }
        .page { margin-bottom: 50px; border-bottom: 2px solid #ccc; padding-bottom: 30px; }
        .title { font-size: 1.3em; font-weight: bold; margin: 20px 0; }
        .text { margin: 15px 0; line-height: 1.6; }
        .figure { margin: 20px 0; text-align: center; }
        .figure img { max-width: 100%; height: auto; border: 1px solid #ddd; }
        .figure-caption { font-style: italic; color: #666; margin-top: 10px; }
        .metadata { background: #f5f5f5; padding: 15px; margin-top: 30px; }
    </style>
</head>
<body>

<h1>Extracted Document</h1>
<p><strong>Source:</strong> data/clinical_files/CDC Influenza vaccines.pdf</p>
<p><strong>Total Pages:</strong> 2</p>
<hr>
<div class="page">
<h2>Page 1</h2>
<div class="title">Fluzone Quadrivalent
(Sanofi Pasteur)
0.5-mL PFS††
≥6 mos††
15 µg/0.5 mL
IM
—
0.5-mL SDV††
≥6 mos††
15 µg/0.5 mL
IM
—
5 0-mL MDV††
≥6 mos††
7 5 µg/0 25 mL
IM
25
¶
¶
¶</div>
<div class="figure">
<img src="figures/figure_p1_0a30bce0.png" alt="[FIGURE 2 - See figure_p1_0a30bce0.png]" style="max-width: 800px;">
<div class="figure-caption">[FIGURE 2 - See figure_p1_0a30bce0.png]</div>
</div>
</div>
<div class="page">
<h2>Page 2</h2>
<div class="figure">
<img src="figures/figure_p2_3b4d312c.png" alt="[FIGURE 1 - See figure_p2_3b4d312c.png]" style="max-width: 800px;">
<div class="figure-caption">[FIGURE 1 - See figure_p2_3b4d312c.png]</div>
</div>
<div class="text">IM-administered influenza vaccines should be administered by needle and syringe only, with the exception of the MDV<br>presentation of Afluria Quadrivalent, which may alternatively be given by the PharmaJet Stratis jet injector for persons ag<br>¶</div>
<div class="text">that any influenza vaccine (egg based or nonegg based) that is otherwise appropriate for the recipient’s age and health<br>status can be used (see Persons with a History of Egg Allergy).<br>The approved dose volume for Afluria Quadrivalent is 0.25 mL for children aged 6 through 35 months and 0.5 mL for<br>persons aged ≥3 years. However, 0.25-mL prefilled syringes are no longer available. For children aged 6 through 35<br>§</div>
<div class="text">Availability and characteristics of specific products and presentations might change or differ from what is described in this<br>table and in the text of this report.<br>Although a history of severe allergic reaction (e.g., anaphylaxis) to egg is a labeled contraindication to the use of egg-based<br>†</div>
<div class="text">* Manufacturer package inserts and updated CDC and ACIP guidance should be consulted for additional information<br>concerning, but not limited to, indications, contraindications, warnings, and precautions. Package inserts for U.S.-licensed</div>
<div class="text">FluMist Quadrivalent<br>(AstraZeneca)<br>0.2-mL prefilled single-<br>use intranasal sprayer<br>2 through 49 yrs 10<br>fluorescent<br>focus units/0.2 mL<br>NAS<br>—<br>Abbreviations: ACIP = Advisory Committee on Immunization Practices; HA = hemagglutinin; IIV4 = inactivated influenza<br>vaccine, quadrivalent; IM = intramuscular; LAIV4 = live attenuated influenza vaccine, quadrivalent; MDV = multidose vial;<br>6.5–7.5</div>
<div class="text">(egg based vaccine )</div>
<div class="title">(Sanofi Pasteur)</div>
<div class="title">Fluad Quadrivalent
(Seqirus)
0.5-mL PFS
≥65 yrs
15 µg/0.5 mL
IM
—
RIV4 (recombinant HA vaccine)
¶</div>
</div>
<div class="metadata">
<h3>Extraction Metadata</h3>
<p>Text blocks: 9</p>
<p>Figures/Tables: 2</p>
</div>

</body>
</html>
